<?xml version="1.0" encoding="UTF-8"?>
<ref id="R12">
 <label>12.</label>
 <mixed-citation publication-type="other">Drug Enforcement Administration. Letter to DEA Qualifying Practitioners. 
  <ext-link ext-link-type="uri" xlink:href="https://www.samhsa.gov/sites/default/files/dea-samhsa-buprenorphine-telemedicine.pdf?mc_cid=8dffbfc637%26mc_eid=d4494a732e" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.samhsa.gov/sites/default/files/dea-samhsa-buprenorphine-telemedicine.pdf?mc_cid=8dffbfc637&amp;mc_eid=d4494a732e</ext-link>. Published Mar 31, 2020. Accessed April 1, 2020.
 </mixed-citation>
</ref>
